Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Hoyerswerda

3 clinical trials in Hoyerswerda, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Hoyerswerda at a glance
3
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Hoyerswerda

Open in trial search

IgA nephropathy

Recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ZIGAKIBART
  • Sponsor:Novartis Pharma AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma GmbH

Hypercholesterolaemia

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Hoyerswerda

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on hypercholesterolemia management are evaluating new therapeutic approaches for patients with elevated LDL cholesterol levels. These studies aim to assess the effectiveness of novel treatments in combination with standard lipid-lowering therapies.

  • LDL Cholesterol Management
  • Cardiovascular Disease Prevention
  • Lipid-Lowering Therapies

Research includes comparative studies of different treatment options to optimize cholesterol management strategies.

02 Nephrology Studies

Groundbreaking research is underway in the field of IgA Nephropathy, investigating novel treatments for this chronic kidney condition. The studies focus on preventing progressive loss of renal function and reducing proteinuria in affected patients.

  • Kidney Disease Management
  • Proteinuria Reduction
  • Renal Function Preservation

These trials represent significant advances in addressing rare kidney disorders through targeted therapeutic approaches.

03 Quality of Life Assessment

Clinical research programs are examining the impact of cardiovascular treatments on patient quality of life, combining therapeutic efficacy with patient-centered outcomes. Studies evaluate both clinical endpoints and patient experience measures.

  • Patient-Reported Outcomes
  • Treatment Effectiveness
  • Safety Monitoring

This research emphasizes the importance of considering both clinical efficacy and patient well-being in treatment approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.